MetLife is projected to deliver quarterly earnings per share of approximately $2.40 for the period ended December 31, driven by a 6% increase in net investment income and an anticipated 4% rise in underwriting profit. Total revenue is expected to climb by 3.5% year-over-year, underpinned by higher premium collections in both life and group benefits segments.

The company reports a 7% year-over-year growth in total premiums, with U.S. life insurance premiums up 5% and International segment premiums rising 10%, led by Latin America and Asia. Stronger policyholder retention rates—improving by 120 basis points globally—are boosting recurring earnings and supporting MetLife’s targeted return on equity of 18% for the full fiscal year.

In the latest Form 13F filings, Alpha Cubed Investments trimmed its MetLife stake by 5.3%, selling 7,476 shares to hold 132,858 shares at quarter end. Concurrently, Valley Wealth Managers increased its position by 1.7% to 289,713 shares, and Golden State Wealth Management more than doubled its stake, adding 701 shares for a 105% increase. Overall institutional ownership remains elevated at 95%.

At its recent board meeting, MetLife declared a quarterly dividend of $0.5675 per share, representing an annualized payout ratio of 42.8% and yielding 2.9%. Analyst coverage remains constructive: two firms rate the stock as Strong Buy, nine as Buy and two as Hold, yielding a consensus outperform view. Price targets from leading research houses range between $90 and $101, implying upside potential relative to current consensus estimates.